V. N. Karazin Kharkiv National University Institute of International Education for Study and Research SMART INHALERS Hazim Bulbul, Olga Verzhanska, Oleksii Dimitrov Asthma is a chronic respiratory condition with frequent cough, difficulty in breathing, feeling tired and wheezing. Asthma affects approximately 300 million people around the world. In children, males have a higher asthma risk; in adults, females have a higher prevalence. The main causes of asthma are environmental factors, genetic factors, allergy, humidity and smoking. Asthma can affect the trachea, bronchi, and bronchioles.Edema, excessive mucus, and epithelial and muscle damage can lead to bronchoconstriction with bronchospasm. The drugs which are used at asthma treatment are divided into two types: controller drugs and relaxing drugs. They can be applied by inhalation, oral use and parenteral injection. Inhaled therapy rightsizes the transfer of the drugs to action radius as opposed to systemic administration of the medicine. Inhaler stereoids, leukotriene antagonists, theophylline, tiotropium and Anti-IgE are mainly used at asthma treatment. Metered dose inhalers, accuhalers, turbuhalers and autohalers are main types of inhalers. • SMART INHALER Smart inhalers have special device which records the date and time of each dose and whether it was correctly administered. Using less reliever medicine, better asthma control, improved quality of life, increased patient involvement and motivation for treating, and more informed decision-making for clinicians are some benefits of smart inhalers. It was shown that integration between technology and medical devices makes patients’ lives easier. Devices for asthma treatment are rapidly developing, and will continue to develop, with new features assisting their introduction into everyday treatment for asthma patients. Thanks